Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH

被引:317
|
作者
Pierantonelli, Irene [1 ]
Svegliati-Baroni, Gianluca [1 ,2 ]
机构
[1] Univ Politecn Marche, Dept Gastroenterol, Via Tronto 10, I-60126 Ancona, Italy
[2] Univ Politecn Marche, Obes Ctr, Ancona, Italy
关键词
ENDOPLASMIC-RETICULUM STRESS; ALLEVIATES INSULIN-RESISTANCE; ADIPOSE TRIGLYCERIDE LIPASE; UNFOLDED PROTEIN RESPONSE; GUT MICROBIOTA; OXIDATIVE STRESS; HEPATOCELLULAR-CARCINOMA; HEPATIC STEATOSIS; LIPID-METABOLISM; FREE-CHOLESTEROL;
D O I
10.1097/TP.0000000000002480
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) represents a growing cause of chronic liver injury, especially in western countries, where it is becoming the most frequent indication for liver transplantation. Nonalcoholic fatty liver disease encompasses a spectrum of diseases that from simple steatosis (pure NAFLD) can progress to nonalcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma. The pathogenesis of NAFLD and the mechanisms behind its progression to NASH have been extensively studied. However, although the processes that determine fat accumulation are mostly clear, the mechanisms associated with the progression of the disease are not fully characterized. In predisposed patients, lipid accumulation can promote lipotoxicity and mitochondrial dysfunction, thus triggering hepatocyte death, inflammation and fibrosis. The specific role of different lipids has been identified and free fatty acids as well as free cholesterol have been identified as toxic species. To make the picture more complex, the pathogenesis of NAFLD involves pathological connections between several organs, including the adipose tissue and the gut, with the liver. The "inflamed" adipose tissue plays a key role in the release of toxic lipids, whereas alterations in the gut-liver axis have been associated with the progression from NAFLD to NASH mediated by dysbiosis, alteration of intestinal barrier, and finally bacterial translocation, which can trigger proinflammatory and profibrogenetic pathways, finally leading to cirrhosis development.
引用
收藏
页码:e1 / e13
页数:13
相关论文
共 50 条
  • [1] Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH)
    Ota, Tsuguhito
    CAROTENOIDS: BIOSYNTHETIC AND BIOFUNCTIONAL APPROACHES, 2021, 1261 : 223 - 229
  • [2] Pathology of nonalcoholic fatty liver disease (NAFLD) associated with obesity: pathogenetic mechanisms
    Alberto Videla, Luis
    Maria Obregon, Ana
    Pettinelli, Paulina
    MEDWAVE, 2011, 11 (07):
  • [3] Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
    Duarte, Sebastiao M. B.
    Stefano, Jose Tadeu
    Oliveira, Claudia P.
    ANNALS OF HEPATOLOGY, 2019, 18 (03) : 416 - 421
  • [4] PATHOGENETIC ANALYSIS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) WITH MULTI-CELL-LINEAGE HUMAN LIVER ORGANOIDS
    Zhang, Wenjun
    Park, Yujin
    Thadasina, Deepthi
    Thi Minh Uyen Le
    Li, Ping
    Ekser, Burcin
    HEPATOLOGY, 2023, 78 : S1121 - S1122
  • [5] Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
    Drescher, Hannah K.
    Weiskirchen, Sabine
    Weiskirchen, Ralf
    CELLS, 2019, 8 (08)
  • [6] Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD)
    Gerhardt, Florian
    Petroff, David
    Blank, Valentin
    Boehlig, Albrecht
    van Boemmel, Florian
    Wittekind, Christian
    Berg, Thomas
    Karlas, Thomas
    Wiegand, Johannes
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (06) : 706 - 711
  • [7] Predictive Factors for Nonalcoholic Steatohepatitis (NASH) in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
    Fierbinteanu-Braticevici, Carmen
    Baicus, Cristian
    Tribus, Laura
    Papacocea, Raluca
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2011, 20 (02) : 153 - 159
  • [8] Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in Patients with Morbid Obesity
    Manno, Emilio
    OBESITY SURGERY, 2010, 20 (06) : 811 - 811
  • [9] A Lipidomic Readout of Disease Progression in Nonalcoholic Fatty Liver Disease (NAFLD)
    Pacana, Tommy
    Min, Hae K.
    Patel, Vaishali
    Katainen, Riikka
    Vihervaara, Terhi
    Mirshahi, Faridoddin
    Puri, Puneet
    Sanyal, Arun J.
    HEPATOLOGY, 2013, 58 : 531A - 531A
  • [10] Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease
    Jou, Janice
    Choi, Steve S.
    Diehl, Anna Mae
    SEMINARS IN LIVER DISEASE, 2008, 28 (04) : 370 - 379